Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 1
1915 3
1916 1
1917 1
1919 2
1920 1
1922 3
1924 2
1925 1
1926 3
1927 1
1928 3
1929 1
1931 1
1932 2
1934 1
1935 3
1936 1
1937 2
1938 4
1939 1
1940 1
1941 1
1946 8
1947 6
1948 16
1949 16
1950 10
1951 13
1952 3
1953 12
1954 6
1955 11
1956 11
1957 9
1958 10
1959 6
1960 8
1961 9
1962 2
1963 8
1964 7
1965 11
1966 14
1967 16
1968 24
1969 26
1970 34
1971 29
1972 31
1973 28
1974 43
1975 44
1976 52
1977 50
1978 40
1979 52
1980 37
1981 51
1982 56
1983 35
1984 37
1985 43
1986 50
1987 55
1988 61
1989 63
1990 57
1991 71
1992 55
1993 68
1994 65
1995 68
1996 63
1997 74
1998 53
1999 50
2000 65
2001 68
2002 56
2003 67
2004 81
2005 86
2006 93
2007 88
2008 98
2009 89
2010 102
2011 90
2012 120
2013 104
2014 92
2015 91
2016 110
2017 121
2018 112
2019 102
2020 93
2021 101
2022 116
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

3,739 results
Results by year
Filters applied: . Clear all
Page 1
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, Leonard JP. Bartlett NL, et al. Among authors: fisher ri. J Clin Oncol. 2019 Jul 20;37(21):1790-1799. doi: 10.1200/JCO.18.01994. Epub 2019 Apr 2. J Clin Oncol. 2019. PMID: 30939090 Free PMC article. Clinical Trial.
Antiseizure Drugs and Movement Disorders.
Sáenz-Farret M, Tijssen MAJ, Eliashiv D, Fisher RS, Sethi K, Fasano A. Sáenz-Farret M, et al. Among authors: fisher rs. CNS Drugs. 2022 Aug;36(8):859-876. doi: 10.1007/s40263-022-00937-x. Epub 2022 Jul 21. CNS Drugs. 2022. PMID: 35861924 Review.
The vulnerable versatility of Salmonella antibiotic persisters during infection.
Hill PWS, Moldoveanu AL, Sargen M, Ronneau S, Glegola-Madejska I, Beetham C, Fisher RA, Helaine S. Hill PWS, et al. Among authors: fisher ra. Cell Host Microbe. 2021 Dec 8;29(12):1757-1773.e10. doi: 10.1016/j.chom.2021.10.002. Epub 2021 Nov 2. Cell Host Microbe. 2021. PMID: 34731646 Free article.
Response.
Rajamani A, Galarza L, Sanfilippo F, Wong A, Goffi A, Tuinman P, Mayo P, Arntfield R, Fisher R, Chew M, Slama M, Mackenzie D, Ho E, Smith L, Renner M, Tavares M, Natesh Prabu R, Ramanathan K, Knudsen S, Bhat V, Arvind H, Huang S. Rajamani A, et al. Among authors: fisher r. Chest. 2022 Jun;161(6):e401-e402. doi: 10.1016/j.chest.2022.01.061. Chest. 2022. PMID: 35680334 No abstract available.
Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative.
Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, Hanson I, Almany S, Timmis S, Dixon S, Kolski B, Todd J, Senter S, Marso S, Lasorda D, Wilkins C, Lalonde T, Attallah A, Larkin T, Dupont A, Marshall J, Patel N, Overly T, Green M, Tehrani B, Truesdell AG, Sharma R, Akhtar Y, McRae T 3rd, O'Neill B, Finley J, Rahman A, Foster M, Askari R, Goldsweig A, Martin S, Bharadwaj A, Khuddus M, Caputo C, Korpas D, Cawich I, McAllister D, Blank N, Alraies MC, Fisher R, Khandelwal A, Alaswad K, Lemor A, Johnson T, Hacala M, O'Neill WW; National Cardiogenic Shock Initiative Investigators. Basir MB, et al. Among authors: fisher r. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1173-1183. doi: 10.1002/ccd.28307. Epub 2019 Apr 25. Catheter Cardiovasc Interv. 2019. PMID: 31025538
The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants.
Tatton-Brown K, Zachariou A, Loveday C, Renwick A, Mahamdallie S, Aksglaede L, Baralle D, Barge-Schaapveld D, Blyth M, Bouma M, Breckpot J, Crabb B, Dabir T, Cormier-Daire V, Fauth C, Fisher R, Gener B, Goudie D, Homfray T, Hunter M, Jorgensen A, Kant SG, Kirally-Borri C, Koolen D, Kumar A, Labilloy A, Lees M, Marcelis C, Mercer C, Mignot C, Miller K, Neas K, Newbury-Ecob R, Pilz DT, Posmyk R, Prada C, Ramsey K, Randolph LM, Selicorni A, Shears D, Suri M, Temple IK, Turnpenny P, Val Maldergem L, Varghese V, Veenstra-Knol HE, Yachelevich N, Yates L; Clinical Assessment of the Utility of Sequencing and Evaluation as a Service (CAUSES) Research Study; Deciphering Developmental Disorders (DDD) Study; Rahman N. Tatton-Brown K, et al. Among authors: fisher r. Wellcome Open Res. 2018 Apr 23;3:46. doi: 10.12688/wellcomeopenres.14430.1. eCollection 2018. Wellcome Open Res. 2018. PMID: 29900417 Free PMC article.
3,739 results